内皮细胞增殖标志物Endoglin和PTEN基因在肿瘤新生血管形成的作用
摘要
实验表明,肿瘤是血管生成依赖性的。当实体肿瘤的大小超过1~2mm^3时就需要不断地有新生血管形成为肿瘤提供养分、促进肿瘤细胞增殖和侵袭。研究发现,肿瘤血管内皮细胞的增生速度比正常组织细胞快20~2000倍。作为转化生长因子β(TGF-β)家族受体复合物成分之一的Endoglin及抑癌基因PTEN在肿瘤血管的生成中起着非常重要的作用。
出处
《中国医药》
2010年第5期481-482,共2页
China Medicine
参考文献16
-
1Van den Dfiesche S, Mummery CL, Westermann CJ. Hereditary hemorrhagic telangiectasia:an update on transforming growth factor beta signaling in vasculogenesis and angiogencsis. Cardiovase Res, 2003, 58(1): 20-31.
-
2Gibbs CP, Kukekov VG, Reith JD, et al. Stem like cells in bone sarcomas : implications for tumorigenesis. Neoplasia,2005,7 ( 11 ) : 967-976.
-
3Bertolino P, Deckers M, Lebrin F, et al. Transforming growth factor-betasignal transduction in angiogenesis and vascular disorders. Chest ,2005,128 (6 Suppl) :585s-590s.
-
4Tanaka F, Otake Y, Yanagihara K, et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res, 2001,7 ( 11 ) :3410-3415.
-
5Nachtigal P, Pospisilova N, Veeerova L, et al. Atorvastatin Increases Endoglin, SMAD2, Phosphorylated SMAD2/3 and eNOS Expression in ApoE/LDLR Double Knockout Mice. J Atheroscler Thromb, 2009,16(3) : 265-274.
-
6Yao Y, Pan Y, Chen J, et al. Endoglin ( CD105 ) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Ann Clin Lab Sci ,2007,37 ( 1 ) :39-48.
-
7Tian F, Zhou AX, Smits AM, et al. Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro. Biochem Biophys Res Commun, 2010,392 ( 3 ) : 283- 288.
-
8Randall LM, Monk B J, Darcy KM, et al. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecol Oncol,2009,112 (3) :583-589.
-
9江忠清,钟莉娉,曲军英,郑秀,林岷.Endoglin与血管内皮生长因子和血管内皮生长因子受体2及基质金属蛋白酶9联合表达与宫颈癌血管生成的关系[J].中国医药,2009,4(11):838-841. 被引量:4
-
10王树兴,于春玲,纪宇明,徐希春,辛玲,姜慧峰.星形细胞瘤组织CD105与TGF-β_1的表达及意义[J].临床和实验医学杂志,2009,8(1):1-2. 被引量:2
二级参考文献30
-
1马军,郭敏,李印,唐芙爱,虎建恩,段芳龄.食管鳞癌中TGF-β及其受体调节成分Endoglin/CD105的表达[J].第四军医大学学报,2006,27(14):1308-1311. 被引量:4
-
2Bellone G, Solerio D, Chiusa L, et al. Transforming growth factor-beta binding receptor endoglin ( CD105 ) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence [ J ]. Ann Surg Oncol, 2007,14 ( 11 ) :3232 - 3242.
-
3El-Gohary YM, Silverman JF, Olson PR, et al. Endoglin ( CD105 ) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma[ J ]. Am J Clin Pathol,2007 ,127 (4) :572 - 579.
-
4Gibbs CP, Kukekov VG, Reith JD,et al. Stem-like cells in bone sarcomas : implications for tumorigenesis [ J ]. Neoplasia, 2005,7 ( 11 ) :967 -976.
-
5Bodey B, Bodey B Jr, Siegel SE, et al. Over-expression of endoglin ( CD105 ) : a marker of breast carcinoma-induced neo-vascularization [J]. Anticancer Res, 1998,18(5A) :3621 -3628.
-
6Kumar S, Ghellal A, Li C, et al. Breast carcinoma : vascular density determined using CD105 antibody correlates with tumor prognosis [J]. CancerRes, 1999, 59(4) :856 -861.
-
7Sehirmning R, Marine D. Endoglin ( CD105 ) expression in squamous cell carcinoma of the oral cavity[ J]. Head Neck,2002,24(2) :151 -156.
-
8Munoz R, Arias Y, Ferreras JM, et al. Targeting a marker of the turnout neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b [ J ] , Cancer Lett, 2007, 256 ( 1 ) :73 - 80.
-
9Lee SH, Mizutani N, Mizutani M, et al. Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer[ J] ,Cancer Immunol Immanother, 2006, 55 (12) : 1565 - 1574.
-
10Seon BK, Takahashi N, Haba A, et al. Angiogenesis and metastasis marker of human tumors[J]. Rinsho Byori ,2001,49(10) :1005 -1013.
共引文献22
-
1李晓玲,李晓兰,邓亚丽,谢艳霞.缺氧诱导因子-1α和Ki-67在子宫内膜癌组织中的表达及其生物学行为[J].实用医学杂志,2009,25(24):4111-4113. 被引量:4
-
2董微,许群星,张立军,华绍芳,韩玉环,尹利荣.孕妇血清中可溶性endoglin水平与特发性胎儿生长受限的关系[J].中国医药,2010,5(6):564-566.
-
3江飞云,倪观太.卵巢上皮癌中缺氧诱导因子-1α与肿瘤血管生成的关系[J].肿瘤研究与临床,2010,22(6):410-411. 被引量:3
-
4赵志强,王养民,张斌,景德善,常德辉,鲁守琳,赵玉海.散发性嗜铬细胞瘤中希佩尔林道蛋白与缺氧诱导因子-α的相关性研究[J].现代肿瘤医学,2010,18(8):1581-1583.
-
5高晓旭.子宫内膜癌组织中缺氧诱导因子-1α、血管内皮生长因子基因表达的临床意义[J].中国基层医药,2010,17(20):2759-2760. 被引量:4
-
6朱桢,陶茜,曹海鹏,富学东,张素华.Endoglin在皮肤鳞状细胞癌中的表达[J].国际病理科学与临床杂志,2011,31(1):7-10. 被引量:2
-
7冉凤明,魏万里,胡红艳,王小芳.STAT3、p-STAT3、HIF-1α、VEGF蛋白表达与肺癌侵袭和转移的相关性研究[J].实用医学杂志,2011,27(14):2570-2572. 被引量:15
-
8于笑涵,杨方.Endoglin与肿瘤的血管增殖[J].中国煤炭工业医学杂志,2011,14(8):1258-1260. 被引量:1
-
9孟亚丽,郑燕,王立芹,李学慧,朱振龙,张红真.宫颈鳞癌组织中PINCH和血管内皮生长因子C蛋白表达的研究[J].中国综合临床,2011,27(10):1019-1022. 被引量:1
-
10李琛,陈国强,周园.非小细胞肺癌患者血清可溶性CD105浓度变化的临床研究[J].齐齐哈尔医学院学报,2012,33(19):2589-2590. 被引量:1
-
1刘娟,文静,王晶,谢铮铮.传统中药抗肿瘤血管生成的临床研究进展[J].中国医院用药评价与分析,2010,10(3):287-288. 被引量:7
-
2朱梁军,冯继锋.内皮抑素在肿瘤治疗中的研究进展[J].江苏医药,2003,29(1):48-49.
-
3Br J Cancer:黑色素瘤中microRNA的基因表达差异[J].基层医学论坛,2012,16(23).
-
4Br J Cancer:黑色素瘤中microRNA的基因表达差异[J].基层医学论坛,2012,16(22).
-
5胡啸,陈东.微小染色体维持蛋白5(MCM5)在大肠癌中的表达及意义[J].湖南师范大学学报(医学版),2010,7(3):30-31.
-
6张卫星,沈林,郝万鹏.血清胸苷激酶是评估血液肿瘤治疗和预后的良好增殖标志物[J].现代检验医学杂志,2008,23(4):3-5. 被引量:2
-
7沈翀,劳山,陈罡.肿瘤细胞增殖标志物蛋白功能及意义的研究进展[J].微创医学,2009,4(3):273-275. 被引量:10
-
8高阳,刘永刚,庄竟,张永超.MCM5在贲门癌组织中的表达及临床意义[J].山东医药,2008,48(19):66-67. 被引量:2
-
9华宗荣,李妍晨,刘瑶,黄才斌.VEGF在胃癌中的研究进展[J].赣南医学院学报,2017,37(1):154-157. 被引量:7
-
10冯晓娜,衣甜甜.血管内皮细胞增殖标志物CD105在上皮性卵巢癌血清中的表达水平及意义[J].黑龙江医药科学,2013,36(6):17-18. 被引量:7